Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19922276 | 0.76 | — | — | |
| SCHEMBL11563132 | 0.69 | — | — | |
| SCHEMBL10988057 | 0.67 | — | — | |
| SCHEMBL20676457 | 0.65 | TSHR (0.32) | TSHR | |
| SCHEMBL19922254 | 0.64 | — | — | |
| SCHEMBL13772820 | 0.64 | TSHR (0.42) | TSHR | |
| SCHEMBL23503567 | 0.62 | TSHR (0.35) | TSHR | |
| SCHEMBL28319305 | 0.62 | — | — | |
| SCHEMBL10899908 | 0.62 | TSHR (0.44) | TSHR | |
| SCHEMBL23776161 | 0.61 | TSHR (0.46) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10465283-B2 | Organoplatinum compound for use in the chemical deposition of platinum compound thin films | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2019-11-05 | — | — | US | disclosed |
| EP-3296425-A1 | CHEMICAL VAPOR DEPOSITION STARTING MATERIAL COMPRISING ORGANIC PLATINUM COMPOUND, AND CHEMICAL VAPOR DEPOSITION METHOD USING SAID CHEMICAL VAPOR DEPOSITION STARTING MATERIAL | Tanaka Kikinzoku Kogyo K.K. (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-20180066357-A1 | RAW MATERIAL FOR CHEMICAL DEPOSITION COMPOSED OF ORGANOPLATINUM COMPOUND, AND CHEMICAL DEPOSITION METHOD USING THE RAW MATERIAL FOR CHEMICAL DEPOSITION | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10465283-B2 | Organoplatinum compound for use in the chemical deposition of platinum compound thin films | RNF168, RAD51, SLC7A1 | TSHR 3476/4885 |
| US-20180066357-A1 | RAW MATERIAL FOR CHEMICAL DEPOSITION COMPOSED OF ORGANOPLATINUM COMPOUND, AND CHEMICAL DEPOSITION METHOD USING THE RAW MATERIAL FOR CHEMICAL DEPOSITION | RNF5, RNF168, SETD7 | TSHR 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.